APA (7th ed.) Citation

L, V., MH, S., JF, H., T, B., R, O., K, R., . . . OS, S. (2017). Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 64(12), 1686. https://doi.org/10.1093/cid/cix201

Chicago Style (17th ed.) Citation

L, Vibholm, et al. "Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 64, no. 12 (2017): 1686. https://doi.org/10.1093/cid/cix201.

MLA (9th ed.) Citation

L, Vibholm, et al. "Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 64, no. 12, 2017, p. 1686, https://doi.org/10.1093/cid/cix201.